Profound Medical Corp. (PROF) income statement
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$7.08−0.26 (-3.54%)
Close on Nov 17, 2026Market cap $258.65MP/E –Yield –
Profound Medical Corp. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 71.8%
- Operating margin
- -185.3%
- Net margin
- -171.6%
- Return on equity, FY2025
- -67.1%
Financial strength
- Current ratio
- 6.46
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 420.0%
Valuation
- P/E ratio
- –
- Price to sales
- 13.55
- Price to book
- 5.19
- Dividend yield
- –
See a number that looks wrong?